Decreased Susceptibility to Ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom

Abstract

In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethoprim. Increasing numbers of treatment failures have been noted. Most infections have been in patients with a recent history of travel to India and Pakistan.

Keywords

• Salmonella Typhi
• ciprofloxacin
• decreased susceptibility
• United Kingdom